Tracked deals
11
11 tracked deals across 2021-2025.
Luxembourg, England, Luxembourg
Independent Pan-European private equity firm partnering with management teams to invest responsibly and build multinational, sustainable businesses.
Tracked deals
11
11 tracked deals across 2021-2025.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
10 buyout · 1 recapitalization
Last 4 years
Supporting Data
Fremman Capital and Chequers Capital have executed a put option agreement to acquire Bertin Technologies Group, a European advanced instrumentation provider, from its majority shareholder FCDE alongside management and BNP Paribas Développement. The deal is intended to help Bertin accelerate organic growth, improve operational performance, and expand capabilities and international reach, with co-control planned alongside management subject to approvals and consultation with employee representatives.
Fremman Capital has acquired a majority stake in Italian In Vitro Diagnostics (IVD) company DIESSE Diagnostica Senese from ARCHIMED's MED II. DIESSE, headquartered in Monteriggioni (Siena), Italy, operates a new biotech campus and ~230 employees and will continue to be led by its management team which retains a meaningful minority stake; Fremman plans to further internationalize and grow the business.
Fremman Capital has agreed to acquire a majority stake in German outpatient rehabilitation group rehaneo from European investment company Gimv. The founders Bruno Crone and Christoph Dühr remain significant shareholders and will continue to run the business; the deal is subject to German antitrust approval and is expected to close in Q1 2025.
Fremman Capital has acquired a majority stake in Munich-headquartered IT services platform connexta from AURELIUS Wachstumskapital, with the company's management and sellers remaining as significant minority shareholders. H.I.G. WhiteHorse Europe provided a €90 million debt financing package to support the acquisition and connexta's planned buy-and-build expansion across the German SME market.
Fremman Capital has executed a put option agreement to acquire Innovative Beauty Group (IBG), a beauty and personal care “turn-key” product development and solutions provider, which is part of the Albéa group. The company offers end-to-end product development including ideation, formulation, filling, packaging, and marketing, supported by a global footprint and 300 employees.
Fremman Capital has acquired a majority stake in HT Médica, a leading Spanish provider of radiology and diagnostic imaging services, partnering with the Luna family to support the company's next stage of growth. Fremman will help HT Médica expand its reach, implement technology and drive value creation across its network of 20 diagnostic imaging centres and 2 laboratory centres in Spain.
Funds advised by Apax Partners LLP and funds advised by Fremman Capital agreed to acquire co-controlling stakes in Palex Medical, with Fremman remaining an investor while some of its funds and other minority shareholders sell. Palex, a Sant Cugat del Vallès (Barcelona)-headquartered MedTech distributor with ~928 employees, will partner with Apax and Fremman to accelerate pan-European growth and international expansion; the deal is expected to close in Q4 2023 and financial terms were not disclosed.
Fremman Capital has acquired a majority stake in Kids Planet Day Nurseries, the UK's largest independently owned nursery operator. Founding management and BGF will remain as significant minority shareholders; the investment will fund accelerated national expansion, senior hires and recruitment across Kids Planet's 82 sites serving over 7,500 children.
Fremman has acquired a majority stake in Palex, the leading distributor of high value-added MedTech equipment and solutions in Spain and Portugal, from Ergon Capital Partners and Corpfin Capital. Management, Ergon and Corpfin will remain minority shareholders as Fremman partners with the Palex team to pursue further consolidation and geographic expansion across Iberia and Europe.
Fremman Capital has closed the acquisition of a majority stake in The Natural Fruit Company (TNFC), a leading Spanish citrus processor and distributor, with GPF Capital remaining involved alongside existing shareholders. TNFC, which controls approximately 900 hectares of plantations and operates eight processing facilities (plus a logistics site in Perpignan, France), will pursue organic growth and an active M&A-driven consolidation strategy under Fremman's ownership; financial terms were not disclosed.
Fremman Capital has entered exclusive discussions to acquire a majority stake in VPS, a Rotterdam-headquartered marine fuel testing, inspection and advisory provider. Fremman said it will support VPS's management to expand its testing, data and ESG-focused advisory capabilities; debt financing for the intended transaction will be provided by Bridgepoint Credit and OLB.
Turn tracked acquisition activity into an outreach-ready buyer list.